Rules concerning screening of safety and efficacy on drugs to be eased

Published: 2002-12-30 06:59:00

Updated: 2002-12-30 06:59:00

The Korea Food and Drug Administration (KFDA) said it would re-draft the current rules concerning the screening of safety and efficacy on drugs, in line with the introduction of simplified protocol system for drugs, etc. in clinical phases, being separated from the screening of safety and efficac...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK